ARWR (arrowheadpharma.com) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan Arrowhead Pharma (ARWR)

The price visualization on the GURU.Markets platform for ARWR confirms the strategy of Arrowhead Pharmaceuticals to develop genetic medicines through partnerships with market leaders. The current indicator stands at 17.95, while high R&D costs are weighing on bottom-line profits during the preparation phase for mass product launches. The financial model relies on licensing payments for innovative RNA solutions for liver therapy.

ARWR Arrowhead Corp: Nilai Pasar marang Nilai Buku ing interval 04.07.2022 - 28.10.2026

Rincian metrik keuangan lan pasar Arrowhead Pharma (ARWR)

- rega lan prakiraan konsensus rega:
Bagan rega Arrowhead Pharmaceuticals|ARWR - Konsensus nilai wajar
- data kapitalisasi pasar:
Nilai pasar Arrowhead Pharmaceuticals Inc|ARWR - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Arrowhead Pharmaceuticals|ARWR - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku arrowheadpharma.com|ARWR - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Arrowhead Pharmaceuticals|ARWR - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Arrowhead Pharmaceuticals Inc|ARWR - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Arrowhead Pharmaceuticals Inc|ARWR - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Arrowhead Pharmaceuticals
Analisis wiwitan perusahaan:Arrowhead Pharmaceuticals - ARWR
Produk asli Arrowhead Pharmaceuticals Inc

This indicator measures the market premium over net assets, reflecting the degree of overvaluation or discount of the business value relative to its book value. The current ratio of Arrowhead Pharmaceuticals (ARWR) estimated value to book capital at 17.95 aggregates investor expectations for the company's future success in RNA drug development and the volume of licensing payments from strategic partners.

Pesaing utama

Rasio Nilai Pasar marang Nilai Buku Mirum Pharmaceuticals MIRM|DVAX (Dynavax Technologies) - Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Arbutus Biopharma Corporation ABUS|Kapitalisasi Pasar marang Aset Bersih Inventiva SA|Gyre Corp (GYRE) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku Assembly Corp (ASMB)|Rasio Kapitalisasi Pasar marang Nilai Buku GALT (Galectin Therapeutics Inc.)|Genfit SA - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku DURECT Corp. (DRRX)|ALGS: Nilai Pasar marang Nilai Buku|BIVI (biovieinc.com) - Rasio Nilai Pasar marang Nilai Buku|Galmed Pharmaceuticals Ltd. (GLMD) - Rasio Kapitalisasi marang Aset Bersih|NDRA (ENDRA Life Sciences) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Hepion Pharma (HEPA)